RAC 2.20% $1.78 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-101

  1. 6,972 Posts.
    lightbulb Created with Sketch. 866
    the problem you have is retail aren’t going to be able to fund this forever

    When it is time Dr T will have to make his choice on who he aligns with

    Broker data shows this is a retail stock
    Last edited by Bluegumnuts: 09/07/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.